Neti Pot (Nasal Irrigation) Research

This systematic review evaluated the impact of nasal irrigation and nasal sprays on COVID-19 outcomes, including infection risk, viral load, symptom severity, and disease duration. The authors identified studies examining various saline and antiseptic nasal irrigation protocols used both prophylactically and as treatment.

The findings suggest that regular nasal irrigation can reduce nasopharyngeal viral load, shorten symptom duration, and decrease the severity of COVID-19 illness. Several studies also reported lower rates of COVID-19 infection among healthcare workers and other high-risk groups who practiced routine nasal irrigation.

The review highlights nasal irrigation as a low-cost, accessible intervention that may complement vaccination and other preventive measures. The overall direction of evidence supports nasal irrigation as a beneficial adjunctive strategy for managing respiratory viral infections including COVID-19.

This clinical practice guideline systematically reviewed the evidence on nasal irrigation for chronic rhinosinusitis (CRS) in adults. The guideline development group evaluated studies on irrigation technique, solution tonicity, volume, additives, and device type to formulate evidence-based recommendations.

The guideline strongly recommends nasal saline irrigation as a first-line treatment for CRS, finding that large-volume irrigation (200+ mL) is more effective than low-volume nasal sprays for symptom relief. Both isotonic and hypertonic saline solutions were found effective, with hypertonic solutions offering modest additional benefit for mucociliary clearance.

The authors recommend nasal irrigation both as standalone therapy for mild CRS and as adjunctive treatment alongside intranasal corticosteroids and other medical therapies. The guideline emphasizes that nasal irrigation is safe for long-term use, with proper device hygiene being the primary safety consideration to prevent secondary infections.

This systematic review and meta-analysis examined the efficacy of saline nasal irrigation for treating acute upper respiratory tract infections (URIs) in infants and children. The authors searched multiple databases for RCTs comparing saline nasal irrigation to standard care or no treatment.

The pooled results showed that saline nasal irrigation significantly reduced nasal congestion severity and shortened the overall duration of illness. Children who received nasal irrigation also had reduced use of decongestant medications and fewer days absent from school or daycare.

The review supports saline nasal irrigation as a safe, inexpensive, and effective adjunctive treatment for pediatric URIs. The intervention was well-tolerated across age groups, with minimal adverse effects reported.

This systematic review and meta-analysis evaluated the comparative efficacy of hypertonic versus isotonic saline nasal irrigation for chronic rhinosinusitis (CRS). Seven studies were included in the analysis, providing evidence on symptom outcomes, radiologic findings, and mucociliary function.

Results strongly favored hypertonic saline across most symptom domains. Hypertonic irrigation showed significant advantages in reducing nasal secretion (SMD=1.52), nasal congestion (SMD=1.52), headache (SMD=0.82), and overall symptom burden (SMD=1.63). Mucociliary clearance time also improved more with hypertonic solutions.

However, the two solutions showed no significant difference for olfactory improvement or radiologic score changes on imaging. Hypertonic saline did cause more minor adverse effects such as nasal burning and stinging, but no serious adverse events were reported.

The authors concluded that hypertonic saline irrigation is significantly more effective than isotonic saline for managing CRS symptoms and improving ciliary function, though they noted the need for further research on optimal concentration and application methods.

This systematic review and meta-analysis compared hypertonic saline (HS) to isotonic saline (IS) nasal irrigation for sinonasal diseases. Nine randomized controlled trials with 740 total patients were included.

The pooled analysis found HS significantly superior for symptom reduction (SMD=-0.58) compared to IS. Subgroup analyses revealed notably larger effects in pediatric patients (SMD=-1.22) versus adults (SMD=-0.26), suggesting children may benefit more from hypertonic formulations. High-volume irrigation was also more effective than low-volume methods, and concentrations below 5% hypertonicity showed better results than higher concentrations.

Disease-specific quality of life measured by the SNOT-20 questionnaire showed no meaningful difference between the two saline types. HS did produce more minor adverse effects such as nasal irritation and burning, though no major adverse events were reported in either group.

The findings support hypertonic saline as the preferred concentration for nasal irrigation in sinonasal diseases, particularly for pediatric patients, while acknowledging the tradeoff of slightly increased minor side effects.

This Cochrane review examined the evidence for saline nasal irrigation in treating acute upper respiratory infections (common colds).

Analysis of 5 trials showed benefits for symptom relief, reduced medication use, and fewer days off work/school, supporting nasal irrigation as a safe adjunct treatment.

Definitive Cochrane review on nasal saline irrigation for chronic sinus conditions.

This randomized controlled trial examined daily nasal irrigation using a neti pot for chronic sinusitis symptoms.

Participants using daily saline irrigation showed significantly greater improvement in symptom scores and quality of life compared to those receiving standard care alone.